WEBULL
WebtradeDownload

Earnings Date Could Be A Game Changer For Revvity (RVTY)

Simply Wall St · 2d ago
  • Revvity has set 3 November as the date for its third quarter 2026 results and continues to highlight growth efforts in diagnostics, AI tools, Signals software, reproductive health and ex China immunodiagnostics while facing ongoing pressure from annual sales declines and weaker earnings per share over the past five years.
  • The mix of a premium valuation and a recent focus on higher earnings per share expectations contrasts with a track record of softer organic revenue trends and reduced profitability per sale. This keeps attention firmly on whether Revvity’s current product lines can sustain its growth ambitions without heavy reliance on acquisitions.
  • The next area of focus will be how Revvity’s upcoming earnings date and AI driven diagnostics initiatives could influence the broader investment narrative.

Compare Revvity's premium expectations with a curated group of AI focused opportunities by scanning the 38 profitable AI stocks that aren't just burning cash that already back their stories with real earnings.

What Is Revvity's Investment Narrative?

To be comfortable owning Revvity, you need to buy into a simple idea. The company is trying to turn a broad toolkit in diagnostics, AI powered software and life sciences instruments into steadier earnings power, not just a one off story after a strong share price run. That means execution really matters. Investors are essentially paying a premium P/E multiple today for the possibility that forecast earnings growth of about 22% a year eventually lines up with cash flow, even though revenue forecasts sit nearer 5%.

The new earnings date on 3 November and management’s push to talk up higher earnings per share expectations put execution under a spotlight. In the short term, the key catalysts are whether diagnostics and Signals software demand can support that profit ramp, while profit margins have recently been softer and one off items have clouded results. Pricing power, integration of past deals and the capital needed to keep AI tools competitive all feed into that question. If the premium holds through the next print without a reset, it will say a lot about how much faith the market has in Revvity’s story.

Even so, there is a less obvious pressure point in Revvity’s setup that could matter far more than the next quarter’s EPS beat or miss...

There's only one way to know the right time to buy, sell or hold Revvity. Head to Simply Wall St's company report for the latest analysis of Revvity's Fair Value.

NYSE:RVTY 1-Year Stock Price Chart
NYSE:RVTY 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic analysts on Revvity frame the AI and software rollout as the real swing factor, not the near term earnings date. Before this update, the bullish group were modeling revenue of about US$3.4b and earnings of US$725.8 million by 2029, far above cautious views. This new information could reshape both storylines.

Explore 2 other Revvity fair value estimates, including one that suggests up to 15% upside from the current price.

Reach Your Own Conclusion

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Investment Ideas Beyond Revvity?

If Revvity has sharpened your interest in quality research, it can help to line it up against a wider set of opportunities that fit different risk and income profiles. The Simply Wall St Screener gives you a structured way to do that, so you can see how this stock compares with other listed businesses on the factors you care about most.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.